Carlyle Group Inc. (David Rubenstein) - Significant Ownership

Notable people
David Rubenstein
Signature - Title
/s/ Anne Frederick, Attorney-in-fact - John C. Redett, Chief Financial Officer
Location
Washington, DC
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Carlyle Group Inc..

Significant Ownership of Carlyle Group Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SARO StandardAero, Inc. Common Stock, par value $0.01 per share 45.6% $4.83B -$891M 153M -15.6% Carlyle Group Inc. Jun 30, 2025
COMM CommScope Holding Company, Inc. Common Stock, par value $0.01 per share 17.5% $252M $3.42M 45.9M +1.37% The Carlyle Group Inc. Aug 3, 2025
PHAT Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $43.5M 3.5M Carlyle Group Inc. Aug 28, 2025
NCNA NuCana plc Ordinary Shares, nominal value (pound)0.04 per share 2.4% $2.99M 3.43M The Carlyle Group Inc. Apr 18, 2025
BSM Black Stone Minerals, L.P. Common Units 0% $0 0 The Carlyle Group Inc. Mar 31, 2025

Schedules 13D/G Reported by Carlyle Group Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.